香丹PSS降纤酶联合应用治疗高粘滞血症疗效分析

The Efficacy Analysis of Xiangdan,PSS and Difibrase Combined Therapy in Treating to Blood Hyperviscosity Syndrome

目的:探讨对高粘滞、高脂血症治疗的最佳方案。方法:60例治疗组高粘高脂血症患者予静点香丹、PSS、降纤酶,并予治疗前后血脂及血液流变学多项指标对比。结果:治疗组甘油三脂(TG)、胆固醇(TC)、全血粘度、血浆粘度、红细胞压积、纤维蛋白原较治疗前均明显降低(P<0.05),与对照组对比不仅疗程短、各项指标治疗前后对比疗效显著。结论:三药联合应用治疗高粘滞、高脂血症,异曲同功,取得有别于传统或常规药物组合的治疗效果,但也面临相对较多副作用或并发症的风险,值得同仁们在医疗实践中借鉴与探讨。

Objective： To evaluate the most optimal therapy to blood hyperviscosity and hyperlipidemia. Method： Venous administration of Xiangdan, PSS and Difibrase is applied for 60 patients with blood hyperviscosity and hyperlipidemia, along with pre - test and post - test multiple - index comparison on blood lipid and hemodynamics change. Result： The concentration of triglyceride （ TG）, cholesterol （ TC ）, total blood viscosity, hematocrit, fibrinogen of the patients from treatment group all decrease significantly （ p 〈 0.05 ）, comparing with the placebo group, respectively, along with much shorter hospitalization duration. Conclusion： The combined application of Xiangdan, PSS and Difibrase, differing from the traditional and conventional combinations of drugs, reaches satisfactory outcomes, although it brings relatively more risks of side - effects or complications, which need to be emphasized and noticed by all the doctors.